-
A 38-year-old man returned to the united States from west Africa. He had spent the last 4 months in Liberia and Sierra Leone where he owned farms. Two days before his August 2004 return, he developed fever, chills, and severe sore throat, and shortly after his arrival, he was hospitalized with, in addition to these complaints, diarrhea and back pain.
-
A previously healthy patient presented with a two-day history of nausea, vomiting, hemoptysis, shortness of breath, and fever. His chest X-ray was abnormal, and his WBC on admission was 12,000/mm3, subsequently rising to a peak of 22,400/mm3.
-
The federal government has awarded $232 million to fund research and development of new vaccines against three potential agents of bioterrorism: smallpox, plague, and tularemia.
-
A large number of potentially suspicious letters and packages continue to be reported to federal, state, and local law enforcement and emergency response agencies nationwide, the Nov. 2, 2004, report states. In some instances, these letters or packages may include powders, liquids, or other materials.
-
-
The Department of Defense (DoD) has halted mandatory anthrax vaccinations of military personnel after a ruling by the U.S. District Court for the District of Columbia.
-
While the United States has taken steps to prepare for smallpox bioterrorism event, the nation remains starkly vulnerable to a genetically engineered strain of the deadly virus.
-
FDA has approved a long-acting implant for the palliative treatment of prostate cancer.
-
Studies on HCV infection resolution show that PBMC HCV-RNA may remain, despite clearance of the virus from plasma.
-
Exenatide (Extendin-4) significantly lowered HbA1C and caused weight loss in type 2 diabetes patients.
